Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2016 Update

Report code: GDME791PD

Publisher: GlobalData

Formats: PDF

Published: June 29, 2016

Number of pages: 45

Anika Therapeutics, Inc. (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. Anika is headquartered in Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Anika Therapeutics, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Anika Therapeutics, Inc. Company Snapshot 6

Anika Therapeutics, Inc. Company Overview 6

Anika Therapeutics, Inc. Pipeline Products and Clinical Trials Overview 7

Anika Therapeutics, Inc. – Pipeline Analysis Overview 10

Business Description 10

Key Facts 10

Anika Therapeutics, Inc. - Major Products and Services 12

Anika Therapeutics, Inc. Pipeline Products by Development Stage 14

Anika Therapeutics, Inc. Clinical Trials by Trial Status 16

Anika Therapeutics, Inc. Pipeline Products Overview 18

Cingal 18

Cingal Product Overview 18

Cronofill 19

Cronofill Product Overview 19

Hemostatic Patch 20

Hemostatic Patch Product Overview 20

HYAFF Barrier Film 21

HYAFF Barrier Film Product Overview 21

HYAFF Gel 22

HYAFF Gel Product Overview 22

HYAFF Mesh 23

HYAFF Mesh Product Overview 23

HYAFF/ACP Spray - Adhesion 24

HYAFF/ACP Spray - Adhesion Product Overview 24

Hyalobone 25

Hyalobone Product Overview 25

Hyalofast 26

Hyalofast Product Overview 26

Hyalofast Clinical Trial 27

Hyaloglide 28

Hyaloglide Product Overview 28

Hyalograft C Autograft 29

Hyalograft C Autograft Product Overview 29

Hyalonect 30

Hyalonect Product Overview 30

INCERT-S 31

INCERT-S Product Overview 31

MONOVISC - Hip 32

MONOVISC - Hip Product Overview 32

MONOVISC - Hip Clinical Trial 33

Next Generation ELEVESS Dermal Filler 34

Next Generation ELEVESS Dermal Filler Product Overview 34

Anika Therapeutics, Inc. - Key Competitors 35

Anika Therapeutics, Inc. - Key Employees 36

Anika Therapeutics, Inc. - Key Employee Biographies 37

Anika Therapeutics, Inc. - Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 39

Anika Therapeutics, Inc., Recent Developments 39

Jun 01, 2016: Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis 39

May 19, 2016: Pendopharm Announces Canadian Launch Of Cingal In Partnership With Anika Therapeutics 39

Apr 27, 2016: Anika Reports First Quarter 2016 Financial Results 40

Apr 04, 2016: Anika Appoints New Chief Medical Officer and Chief Operations Officer 40

Mar 28, 2016: Anika Therapeutics Wins CE Mark Approval For Cingal For The Treatment Of Pain Associated With Osteoarthritis Of The Knee 41

Feb 24, 2016: Anika Therapeutics Delivers Strong Performance with Record Product Revenue for the Fourth Quarter and Full Year 2015 42

Dec 29, 2015: Anika Therapeutics Announces First Patient Enrolled in FastTRACK Phase III HYALOFAST Study 43

Dec 09, 2015: Anika Therapeutics Announces Decision to Proceed with CINGAL Premarket Review Through FDA's Center for Drug Evaluation and Research 43

Nov 03, 2015: Anika Therapeutics Announces Health Canada Approval of CINGAL for the Treatment of Pain Associated with Osteoarthritis of the Knee 44

Oct 29, 2015: Anika Appoints Richard Hague to Role of Chief Commercial Officer 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Tables

List of Tables

Anika Therapeutics, Inc. Pipeline Products and Clinical Trials Overview 7

Anika Therapeutics, Inc. Pipeline Products by Equipment Type 7

Anika Therapeutics, Inc. Pipeline Products by Indication 9

Anika Therapeutics, Inc. Clinical Trials by Trial Status 9

Anika Therapeutics, Inc., Key Facts 11

Anika Therapeutics, Inc., Major Products and Services 12

Anika Therapeutics, Inc. Number of Pipeline Products by Development Stage 14

Anika Therapeutics, Inc. Pipeline Products Summary by Development Stage 15

Anika Therapeutics, Inc. Clinical Trials by Trial Status 16

Anika Therapeutics, Inc. Clinical Trials Summary 17

Cingal - Product Status 18

Cingal - Product Description 18

Cronofill - Product Status 19

Cronofill - Product Description 19

Hemostatic Patch - Product Status 20

Hemostatic Patch - Product Description 20

HYAFF Barrier Film - Product Status 21

HYAFF Barrier Film - Product Description 21

HYAFF Gel - Product Status 22

HYAFF Gel - Product Description 22

HYAFF Mesh - Product Status 23

HYAFF Mesh - Product Description 23

HYAFF/ACP Spray - Adhesion - Product Status 24

HYAFF/ACP Spray - Adhesion - Product Description 24

Hyalobone - Product Status 25

Hyalobone - Product Description 25

Hyalofast - Product Status 26

Hyalofast - Product Description 26

Hyalofast - HYALOFAST FastTRACK Phase III Clinical Study 27

Hyaloglide - Product Status 28

Hyaloglide - Product Description 28

Hyalograft C Autograft - Product Status 29

Hyalograft C Autograft - Product Description 29

Hyalonect - Product Status 30

Hyalonect - Product Description 30

INCERT-S - Product Status 31

INCERT-S - Product Description 31

MONOVISC - Hip - Product Status 32

MONOVISC - Hip - Product Description 32

MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip 33

Next Generation ELEVESS Dermal Filler - Product Status 34

Next Generation ELEVESS Dermal Filler - Product Description 34

Anika Therapeutics, Inc., Key Employees 36

Anika Therapeutics, Inc., Key Employee Biographies 37

Anika Therapeutics, Inc., Subsidiaries 38

List of Figures

List of Figures

Anika Therapeutics, Inc. Pipeline Products by Equipment Type 8

Anika Therapeutics, Inc. Pipeline Products by Development Stage 14

Anika Therapeutics, Inc. Clinical Trials by Trial Status 16

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP